Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dc9f789b-d33f-437e-af62-c833d1860b8d
Date 10/2/2013
Company Name Tetra Discovery Partners
Mailing Address 301 Michigan Street NE Grand Rapids, MI 49503
Company Description Our research focuses on developing new treatments for depression based on subtype-selective modulation of phosphodiesterase 4B (PDE4B). PDE4 in neurons is responsible for the hydrolysis of cAMP. We and our colleagues recently described the protein structure of a key PDE4 regulatory domain known as UCR2.
Proceeds Purposes The company intends to use the funds to develop an innovative drug to treat cognitive impairment caused by Alzheimer’s disease, and a second drug to treat depression and restore cognitive function in patients who have suffered traumatic brain injury (TBI).
M&A Terms
Venture Investor Grand Angels
Venture Investor Biosciences Research and Commercialization Center
Venture Investor Michigan Pre-Seed Capital Fund
Venture Investor Michigan Economic Development Corporation